Phase 1 Fabry Disease Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
Fabry Disease
UniQure Biopharma B.V.12 enrolled8 locationsNCT06270316
Recruiting
Phase 1Phase 2
4D-310 in Adults With Fabry Disease and Cardiac Involvement
Fabry Disease
4D Molecular Therapeutics18 enrolled4 locationsNCT05629559